Volterra Technologies’s DexCom DXCM Stock Holding History

Volterra Technologies’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-8,226	Closed	-$546K	–	347
2025 Q4	$546K	Sell	8,226 -5,143	-38%	-$332K	0.06%	237
2025 Q3	$900K	Buy	+13,369	New	+$1.06M	0.08%	194

Other funds holding DXCM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Volterra Technologies's DXCM Position: Q1 2026 in Review

Volterra Technologies sold out of DexCom (DXCM) in Q1 2026, closing a stake of 8,226 shares — an estimated $546K sold.

Volterra Technologies first reported a position in DXCM in Q3 2025 and held it in 2 quarters. The position peaked at $900K in Q3 2025. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

Volterra Technologies reported no remaining DexCom position as of Q1 2026 after selling out during the quarter.
Volterra Technologies sold 8,226 DexCom shares in Q1 2026, an estimated $546K.
Volterra Technologies first reported a position in DexCom in Q3 2025 and held it in 2 quarters.
Volterra Technologies's DexCom position peaked at $900K in Q3 2025.
956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Volterra Technologies's 13F filing for Q1 2026, filed 14 May 2026.